Soble J J, Streem S B
Department of Urology, The Cleveland Clinic Foundation, Ohio 44195, USA.
Tech Urol. 1998 Jun;4(2):58-64.
Cystinuria is an inherited genetic disorder that results in excessive cystine excretion through defects in renal dibasic amino acid transport. Due to the relative insolubility of cystine in urine, patients with this condition are prone to progressive and recurrent episodes of stone formation. Medical treatment is aimed at decreasing the concentration of cystine in the urine as well as increasing its solubility. A standard regimen includes dietary manipulation with hydration and moderate salt restriction, alkalinization, and thiol derivatives. Despite aggressive medical management, cystinuric patients are likely to suffer stone recurrences, and urologic intervention often is required. Contemporary technology permits the use of minimally invasive techniques for the majority of these patients, and advances in shock wave lithotripsy, percutaneous nephrolithotomy, and ureteroscopic lithotripsy obviate the need for open surgery in essentially all instances.
胱氨酸尿症是一种遗传性基因疾病,由于肾脏二碱基氨基酸转运缺陷导致胱氨酸排泄过多。由于胱氨酸在尿液中的相对不溶性,患有这种疾病的患者容易出现渐进性和复发性结石形成。医学治疗旨在降低尿液中胱氨酸的浓度并增加其溶解度。标准治疗方案包括饮食调整、补充水分、适度限制盐分、碱化尿液以及使用硫醇衍生物。尽管进行了积极的医学管理,胱氨酸尿症患者仍可能出现结石复发,通常需要泌尿外科干预。当代技术允许对大多数此类患者使用微创技术,并且冲击波碎石术、经皮肾镜取石术和输尿管镜碎石术的进展使得在基本上所有情况下都无需进行开放手术。